e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Haemonetics Corp
(NY:
HAE
)
71.48
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8
Open
71.48
Bid (Size)
28.60 (2)
Ask (Size)
77.00 (1)
Prev. Close
71.48
Today's Range
71.48 - 71.48
52wk Range
70.25 - 97.97
Shares Outstanding
51,029,618
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NYSE:HAE is not too expensive for the growth it is showing.
October 31, 2024
While growth is established for NYSE:HAE, the stock's valuation remains reasonable.
Via
Chartmill
Despite its growth, NYSE:HAE remains within the realm of affordability.
October 10, 2024
HAEMONETICS CORP/MASS (NYSE:HAE), a growth stock which is not overvalued.
Via
Chartmill
Performance
YTD
-16.04%
-16.04%
1 Month
-8.23%
-8.23%
3 Month
-17.46%
-17.46%
6 Month
-25.06%
-25.06%
1 Year
-19.20%
-19.20%
More News
Read More
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
September 24, 2024
From
Aligos Therapeutics
Via
GlobeNewswire
NYSE:HAE stands out as a growth opportunity that won't break the bank.
September 18, 2024
Via
Chartmill
What Analysts Are Saying About Haemonetics Stock
September 10, 2024
Via
Benzinga
Investors should take note of NYSE:HAE, a growth stock that remains attractively priced.
August 28, 2024
Via
Chartmill
Analyst Expectations For Haemonetics's Future
August 22, 2024
Via
Benzinga
NYSE:HAE stands out as a growth opportunity that won't break the bank.
July 16, 2024
Via
Chartmill
Top 3 Health Care Stocks That Are Set To Fly This Quarter
August 16, 2024
Via
Benzinga
Investors should take note of NYSE:HAE, a growth stock that remains attractively priced.
August 06, 2024
Via
Chartmill
Sotera Health Appoints Christopher Simon to the Board of Directors
August 01, 2024
From
Sotera Health Services, LLC
Via
GlobeNewswire
Looking for growth without the hefty price tag? Consider NYSE:HAE.
June 25, 2024
Via
Chartmill
Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst
June 12, 2024
Via
Benzinga
NYSE:HAE, a growth stock which is not overvalued.
June 03, 2024
Via
Chartmill
4 Analysts Assess Haemonetics: What You Need To Know
May 10, 2024
Via
Benzinga
Earnings Scheduled For February 8, 2024
February 08, 2024
Via
Benzinga
Is HAEMONETICS CORP/MASS (NYSE:HAE) suited for quality investing?
October 09, 2023
Via
Chartmill
This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
June 12, 2024
Via
Benzinga
These 3 Companies Boast Bright Outlooks
June 05, 2024
Via
Talk Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 21, 2024
Via
Benzinga
HAE Stock Earnings: Haemonetics Beats EPS, Beats Revenue for Q4 2024
May 09, 2024
Via
InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:HAE is worth considering.
April 05, 2024
Via
Chartmill
Intuitive Surgical Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
November 17, 2023
Via
Investor's Business Daily
Intuitive Surgical Stock Rating Climbs As Sales, Profits Rise
October 16, 2023
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
October 10, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert
